Single-dose nonsteroidal anti-inflammatory drugs in horses have no impact on concentrations of cytokines or growth factors in autologous protein solution and platelet-rich plasma

Am J Vet Res. 2024 Feb 15;85(4):ajvr.23.11.0258. doi: 10.2460/ajvr.23.11.0258. Print 2024 Apr 1.

Abstract

Objective: To determine the effects of a single dose of the NSAIDs phenylbutazone, firocoxib, flunixin meglumine, and ketoprofen on concentrations of growth factors and cytokines in autologous protein solution (APS) and platelet-rich plasma (PRP).

Animals: 6 adult university-owned horses.

Methods: For the first phase, 6 horses were randomized to receive ketoprofen (1,000 mg) or flunixin meglumine (500 mg) IV. Blood was obtained and processed for APS (Pro-Stride) and PRP (Restigen) before and 6 hours after administration of NSAIDs. Horses underwent a 2-week washout period, after which the protocol was repeated using a crossover design. For the second phase, following at least a 2-week washout period, the study protocol was repeated with phenylbutazone (1 g) or firocoxib (57 mg) administered orally. Plasma was collected 6 hours after administration for evaluation of drug concentrations, and APS and PRP were analyzed for concentrations of drug, platelets, leukocytes, and several growth factors and cytokines (PDGF, fibroblast growth factor, TGF-β1, IL-1β, IL-10, IL-6, IL-8, and tumor necrosis factor-α) before and 6 hours after administration of NSAIDs using immunoassays.

Results: There were no significant differences in concentrations of cytokines or growth factors before or after administration of any NSAID. There were significant differences in concentrations of leukocytes and platelets based on both product and time. NSAID concentrations in plasma were not significantly different from concentrations in APS and PRP.

Clinical relevance: These results help guide clinicians on the appropriate use of these NSAIDs in conjunction with the processing of APS and PRP, which is unlikely to significantly alter the final product after single-dose administration.

Keywords: autologous protein solution; cytokines; growth factors; nonsteroidal anti-inflammatory drugs; platelet-rich plasma.

MeSH terms

  • 4-Butyrolactone / administration & dosage
  • 4-Butyrolactone / adverse effects
  • 4-Butyrolactone / analogs & derivatives
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal* / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal* / adverse effects
  • Cytokines* / blood
  • Cytokines* / metabolism
  • Horses* / blood
  • Horses* / metabolism
  • Ketoprofen / administration & dosage
  • Ketoprofen / adverse effects
  • Phenylbutazone / administration & dosage
  • Phenylbutazone / adverse effects
  • Platelet-Rich Plasma* / metabolism
  • Random Allocation
  • Sulfones / administration & dosage
  • Sulfones / adverse effects

Substances

  • 4-Butyrolactone
  • Anti-Inflammatory Agents, Non-Steroidal
  • Cytokines
  • firocoxib
  • Ketoprofen
  • Phenylbutazone
  • Sulfones